Author

A. Rynne-Vidal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Jimenez-Segovia· 1 shared A. Mota· 1 shared A. Rojo-Sebastian· 1 shared B. Barrocal· 1 shared G. Moreno-Bueno· 1 shared K. Stamatakis· 1 shared L. J. A. C. Hawinkels· 1 shared M. Fresno· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Jimenez-Segovia

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Prostaglandin F2α-induced TGFβ-PMEPA1 pathway is a critical mediator of epithelial plasticity and ovarian carcinoma progression.

A. Jimenez-Segovia, A. Mota, A. Rojo-Sebastian, B. Barrocal, A. Rynne-Vidal, M. L. Garcia-Bermejo, R. Gomez-Bris, L. J. A. C. Hawinkels, P. Sandoval, R. Garcia-Escudero, M. Lopez-Cabrera, G. Moreno-Bueno, M. Fresno, K. Stamatakis

This paper identifies PGF2α-induced TGFβ-PMEPA1 pathway as a driver of epithelial plasticity and ovarian cancer progression, with PMEPA1 as a therapeutic target and prognostic biomarker.

bioRxiv · Sep 18, 2018Cancer Biology